Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

Abstract

A revised 2021 COG neuroblastoma risk classifier (version 2) that uses the INRGSS and incorporates SCAs has been adopted to prospectively define COG clinical trial eligibility and treatment assignment.